NCT03494686

Brief Summary

The investigators conduct a prospective, randomized trial to assess the benefits of performing large loop excision of the transformatione zone (LLETZ) under local anesthesia and compare it to LLETZ under general anesthesia. The primary endpoint of this study is women´s satisfaction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
229

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2018

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 3, 2018

Completed
Same day until next milestone

Study Start

First participant enrolled

April 3, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 11, 2018

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2020

Completed
15 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 14, 2020

Completed
Last Updated

March 23, 2020

Status Verified

March 1, 2020

Enrollment Period

1.9 years

First QC Date

April 3, 2018

Last Update Submit

March 19, 2020

Conditions

Keywords

conizationLLETZrandomized controlled trialloop excisiongeneral anaesthesialocal anaesthesia

Outcome Measures

Primary Outcomes (1)

  • Womens satisfaction

    Patients will score their satisfaction by using a 11-step visual analogue scale (VAS) ranging from '0' ("not satisfied at all") to '10' ("very satisfied") 2 hours after Treatment

    2 hours

Secondary Outcomes (10)

  • Postoperative pain

    2 hours

  • the resected cone mass

    10 minutes

  • Operation time

    20 minutes

  • Operative complications

    14 days

  • Time to complete intraoperative hemostasis

    120 seconds

  • +5 more secondary outcomes

Study Arms (2)

LLETZ under local anaesthesia

EXPERIMENTAL

The LLETZ procedure will be performed under local anaesthesia

Procedure: LLETZ under local anaesthesia

LLETZ under general anaesthesia

ACTIVE COMPARATOR

The LLETZ procedure will be performed under general anaesthesia

Procedure: LLETZ under general anaesthesia

Interventions

Conization will be performed under local anaesthesia

LLETZ under local anaesthesia

Conization will be performed under general anaesthesia

LLETZ under general anaesthesia

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • colposcopy Prior to conization
  • informed consent
  • histologically proven high grade cervical dysplasia
  • Transformation zone typ 1 or 2

You may not qualify if:

  • significant language barrier
  • a personal history of conization
  • pregnancy
  • the use of blood thinner
  • unwillingness to participate
  • oncological disease
  • inpatient treatment
  • women who are not fasting
  • risk of aspiration
  • columnar-squamous epithelium border not fully visible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology of the Ruhr University Bochum

Herne, North Rhine-Westphalia, 44625, Germany

Location

Related Publications (1)

  • Rezniczek GA, Hecken JM, Rehman S, Dogan A, Tempfer CB, Hilal Z. Syringe or mask? Loop electrosurgical excision procedure under local or general anesthesia: a randomized trial. Am J Obstet Gynecol. 2020 Dec;223(6):888.e1-888.e9. doi: 10.1016/j.ajog.2020.06.041. Epub 2020 Jul 24.

MeSH Terms

Conditions

Uterine Cervical Dysplasia

Condition Hierarchy (Ancestors)

Precancerous ConditionsNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Study Officials

  • Ziad Hilal, M.D.

    Zydolab - Institute of Cytology and Immune Cytochemistry

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2018

First Posted

April 11, 2018

Study Start

April 3, 2018

Primary Completion

February 28, 2020

Study Completion

March 14, 2020

Last Updated

March 23, 2020

Record last verified: 2020-03

Data Sharing

IPD Sharing
Will not share

Locations